Peripheral artery disease and clinical outcomes in patients with atrial fibrillation: A systematic review and meta-analysis
- PMID: 34170015
- PMCID: PMC8364730
- DOI: 10.1002/clc.23678
Peripheral artery disease and clinical outcomes in patients with atrial fibrillation: A systematic review and meta-analysis
Abstract
Background: Atrial fibrillation (AF) is the most common cardiac rhythm disturbance and leads to morbidity and mortality. Peripheral artery disease (PAD) is associated with atherosclerotic risk factors and always classified as a vascular disease and deemed to be a bad complication of AF. In patients with AF, the risk and prognostic value of PAD have not been estimated comprehensively.
Hypothesis: PAD is associated with all-cause mortality, cardiovascular (CV) mortality, and other outcomes in patients with AF.
Methods: We searched PubMed, Embase, and Cochrane Library databases for prospective studies published before April 2021 that provided outcomes data on PAD in confirmed patients with AF. Heterogeneity was estimated using the I2 statistic. The fixed-effects model was used for low to moderate heterogeneity studies, and the random-effects model was used for high heterogeneity studies.
Results: Eight prospective studies (Newcastle-Ottawa score range, 7-8) with 39 654 patients were enrolled. We found a significant association between PAD and all-cause mortality (hazard ratio [HR], 1.42; 95% confidence interval [CI], 1.25-1.62; p < .001), CV mortality (HR, 1.64; 95% CI, 1.32-2.05; p < .001) and MACE (HR, 1.75; 95% CI, 1.38-2.22; p < .001) in patients with AF. No significant relationship was found in major bleeding (HR, 1.22; 95% CI, 0.95-1.57; p = 0.118), myocardial infarction (MI) (HR, 2.07; 95% CI, 1.17-3.67; p = .038), and stroke (HR, 1.14; 95% CI, 0.87-1.50, p = 0.351).
Conclusions: PAD is associated with an increased risk of all-cause mortality, CV mortality, and MACE in patients with AF. However, no significant association was found with major bleeding, MI, and stroke.
Keywords: atrial fibrillation; cardiovascular events; major bleeding; meta-analysis; mortality; outcome; peripheral artery disease; stroke.
© 2021 The Authors. Clinical Cardiology published by Wiley Periodicals LLC.
Figures
Similar articles
-
Smoking cessation for secondary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2022 Aug 8;8(8):CD014936. doi: 10.1002/14651858.CD014936.pub2. Cochrane Database Syst Rev. 2022. PMID: 35938889 Free PMC article.
-
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2. Cochrane Database Syst Rev. 2022. PMID: 35199850 Free PMC article.
-
Exercise-based cardiac rehabilitation for coronary heart disease.Cochrane Database Syst Rev. 2021 Nov 6;11(11):CD001800. doi: 10.1002/14651858.CD001800.pub4. Cochrane Database Syst Rev. 2021. PMID: 34741536 Free PMC article.
-
Interrupted versus uninterrupted anticoagulation therapy for catheter ablation in adults with arrhythmias.Cochrane Database Syst Rev. 2021 Oct 21;10(10):CD013504. doi: 10.1002/14651858.CD013504.pub2. Cochrane Database Syst Rev. 2021. PMID: 34674223 Free PMC article.
-
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2. Cochrane Database Syst Rev. 2022. PMID: 36161421 Free PMC article.
Cited by
-
Direct Oral Anticoagulants as the First Choice of Anticoagulation for Patients with Peripheral Artery Disease to Prevent Adverse Vascular Events: A Systematic Review and Meta-Analysis.J Cardiovasc Dev Dis. 2023 Feb 3;10(2):65. doi: 10.3390/jcdd10020065. J Cardiovasc Dev Dis. 2023. PMID: 36826561 Free PMC article. Review.
-
Heart Failure and Major Adverse Cardiovascular Events in Atrial Fibrillation Patients: A Retrospective Primary Care Cohort Study.Biomedicines. 2023 Jun 26;11(7):1825. doi: 10.3390/biomedicines11071825. Biomedicines. 2023. PMID: 37509465 Free PMC article.
-
Combined use of anticoagulant and antiplatelet on outcome after stroke in patients with nonvalvular atrial fibrillation and systemic atherosclerosis.Sci Rep. 2024 Jan 3;14(1):304. doi: 10.1038/s41598-023-51013-3. Sci Rep. 2024. PMID: 38172278 Free PMC article.
References
-
- Nattel S. New ideas about atrial fibrillation 50 years on. Nature. 2002;415(6868):219‐226. - PubMed
-
- Rahman F, Kwan GF, Benjamin EJ. Global epidemiology of atrial fibrillation. Nat Rev Cardiol. 2014;11(11):639‐654. - PubMed
-
- Hart RG, Halperin JL. Atrial fibrillation and stroke: concepts and controversies. Stroke. 2001;32(3):803‐808. - PubMed
-
- Ruff CT, Bhatt DL, Steg PG, et al. REACH registry investigators. Long‐term cardiovascular outcomes in patients with atrial fibrillation and atherothrombosis in the REACH registry. Int J Cardiol. 2014;170(3):413‐418. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous